Order results by:
| Issue | Title | |
| Vol 6, No 2S (2014): Special issue "Stroke" | Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies | Abstract similar documents |
| V.A. Parfenov, S.V. Verbitskaya | ||
| "... – dabigatran. Presented results ARISTOTLE study, where have defined preference apixaban vs warfarin ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... .0001). In an additional sub-analysis of the ARISTOTLE trial, patients with AF and a history of stroke/transient ischemic ..." | ||
| Vol 16, No 4 (2024) | Ten rules for oral anticoagulants prescription after a stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, D. A. Demin, S. S. Kucherenko | ||
| Vol 12, No 4 (2020) | Atrial fibrillation and cognitive impairment: cerebral microbleeds as a new risk factor and possibilities of anticoagulant therapy (Part 2) | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova | ||
| "... further investigation. At the same time, among the DOACs, apixaban is the only drug that has been proven ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..." | ||
| Vol 8, No 1 (2016) | Hemorrhagic stroke and oral anticoagulants: What is to be done? | Abstract similar documents |
| M. A. Domashenko | ||
| "... ) and novel oral anticoagulants (dabigatran. rivaroxaban, apixaban), as well as an anticoagulant resumption ..." | ||
| Vol 5, No 2 (2013) | Dabigatran experience in primary and secondary prevention of cardioembolic stroke | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova | ||
| "... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..." | ||
| Vol 6, No 4 (2014) | Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... anticoagulants (NOACs), such as dabigatran, rivaroxaban, and apixaban. World clinical experience with NOACs in AF ..." | ||
| Vol 4, No 3 (2012) | A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... antagonists rivaroxaban, apixaban, edoxaban, have been recently designed, clinically tested, and put ..." | ||
| 1 - 9 of 9 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
